GENE ONLINE|News &
Opinion
Blog

Gene Editing
Moderna, Life Edit To Develop In Vivo Gene Editing Therapies
2023-02-23
Treating Common Heart Disease with CRISPR-Cas9 Gene Editing
2022-12-27
Verve and Vertex Agree to Co-Develop In Vivo Gene Editing Program for Liver Disease
2022-07-21
Verve Cleared to Test Gene Editing Drug for Heart Disease in Humans
2022-05-12
TALED Tool Launches a New Era of Mitochondrial Genome Editing
2022-05-03
CRISPR Biotech Editas Obtains FDA Rare Pediatric Disease Label
2022-04-27
FDA Announces Draft Guidances on Genome Editing and CAR T Cell Therapy
2022-03-25
China Pushes for Faster Approval for Gene-Edited Crops
2022-02-15
What If Our Body’s Power Station Goes Wrong? Gene Therapy May Help
2022-02-15
GeneOnline’s Pick: Novel Biotechnologies that Made a Splash in 2021
2022-01-27
GeneOnline’s Top 10 Editor’s Picks for 2021
2021-12-23
Harnessing the potential of CRISPR-Cas9 for Gut Microbiome Gene Editing
2021-11-29
Study Advocates Cautious Application of CRISPR in Designing Therapeutics
2021-11-22
Chroma Medicine Debuts with High Hopes for “Game-Changing” Epigenetic Genome Editors
2021-11-17
Moderna Enters Gene Editing Market with Metagenomi Collaboration
2021-11-03
1 2 3 6
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top